中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/09/27 | 1,621 | 1,655 | 1,616 | 1,653 | +34 | +2.1% | 764,800 |
2012/09/26 | 1,614 | 1,644 | 1,614 | 1,619 | -3 | -0.2% | 643,400 |
2012/09/25 | 1,592 | 1,623 | 1,586 | 1,622 | +19 | +1.2% | 947,200 |
2012/09/24 | 1,601 | 1,619 | 1,598 | 1,603 | -4 | -0.2% | 1,002,200 |
2012/09/21 | 1,590 | 1,615 | 1,579 | 1,607 | +26 | +1.6% | 643,200 |
2012/09/20 | 1,577 | 1,591 | 1,573 | 1,581 | -6 | -0.4% | 1,097,500 |
2012/09/19 | 1,602 | 1,602 | 1,582 | 1,587 | -5 | -0.3% | 752,200 |
2012/09/18 | 1,587 | 1,600 | 1,576 | 1,592 | +13 | +0.8% | 889,600 |
2012/09/14 | 1,600 | 1,606 | 1,571 | 1,579 | -4 | -0.3% | 2,299,800 |
2012/09/13 | 1,586 | 1,588 | 1,572 | 1,583 | -2 | -0.1% | 474,500 |
2012/09/12 | 1,558 | 1,585 | 1,554 | 1,585 | +35 | +2.3% | 506,700 |
2012/09/11 | 1,552 | 1,561 | 1,534 | 1,550 | -1 | -0.1% | 515,600 |
2012/09/10 | 1,543 | 1,555 | 1,535 | 1,551 | +3 | +0.2% | 490,800 |
2012/09/07 | 1,561 | 1,563 | 1,541 | 1,548 | +5 | +0.3% | 649,000 |
2012/09/06 | 1,563 | 1,578 | 1,539 | 1,543 | ±0 | ±0% | 945,300 |
2012/09/05 | 1,529 | 1,555 | 1,523 | 1,543 | +23 | +1.5% | 849,500 |
2012/09/04 | 1,528 | 1,537 | 1,515 | 1,520 | -11 | -0.7% | 719,000 |
2012/09/03 | 1,552 | 1,554 | 1,531 | 1,531 | -29 | -1.9% | 670,600 |
2012/08/31 | 1,554 | 1,578 | 1,552 | 1,560 | -1 | -0.1% | 699,300 |
2012/08/30 | 1,583 | 1,585 | 1,557 | 1,561 | -18 | -1.1% | 379,400 |
2012/08/29 | 1,580 | 1,595 | 1,567 | 1,579 | +5 | +0.3% | 680,200 |
2012/08/28 | 1,599 | 1,599 | 1,569 | 1,574 | -11 | -0.7% | 887,700 |
2012/08/27 | 1,580 | 1,599 | 1,574 | 1,585 | +8 | +0.5% | 654,400 |
2012/08/24 | 1,587 | 1,587 | 1,558 | 1,577 | -9 | -0.6% | 625,300 |
2012/08/23 | 1,572 | 1,590 | 1,563 | 1,586 | +18 | +1.1% | 853,500 |
2012/08/22 | 1,560 | 1,572 | 1,556 | 1,568 | +11 | +0.7% | 448,100 |
2012/08/21 | 1,559 | 1,566 | 1,546 | 1,557 | +1 | +0.1% | 438,900 |
2012/08/20 | 1,547 | 1,566 | 1,541 | 1,556 | +11 | +0.7% | 509,500 |
2012/08/17 | 1,555 | 1,559 | 1,543 | 1,545 | -12 | -0.8% | 436,100 |
2012/08/16 | 1,551 | 1,564 | 1,547 | 1,557 | +10 | +0.6% | 538,000 |
2012/08/15 | 1,543 | 1,547 | 1,528 | 1,547 | +4 | +0.3% | 637,200 |
2012/08/14 | 1,563 | 1,565 | 1,531 | 1,543 | -13 | -0.8% | 1,507,300 |
2012/08/13 | 1,539 | 1,568 | 1,536 | 1,556 | +11 | +0.7% | 463,200 |
2012/08/10 | 1,555 | 1,567 | 1,543 | 1,545 | -26 | -1.7% | 756,000 |
2012/08/09 | 1,564 | 1,577 | 1,540 | 1,571 | +6 | +0.4% | 1,002,400 |
2012/08/08 | 1,555 | 1,575 | 1,552 | 1,565 | +20 | +1.3% | 1,102,200 |
2012/08/07 | 1,519 | 1,549 | 1,514 | 1,545 | +21 | +1.4% | 589,600 |
2012/08/06 | 1,513 | 1,537 | 1,503 | 1,524 | +26 | +1.7% | 846,600 |
2012/08/03 | 1,518 | 1,530 | 1,497 | 1,498 | -38 | -2.5% | 749,100 |
2012/08/02 | 1,544 | 1,555 | 1,532 | 1,536 | -9 | -0.6% | 1,132,000 |
2012/08/01 | 1,525 | 1,550 | 1,517 | 1,545 | +34 | +2.3% | 820,600 |
2012/07/31 | 1,520 | 1,528 | 1,506 | 1,511 | -9 | -0.6% | 571,900 |
2012/07/30 | 1,486 | 1,524 | 1,486 | 1,520 | +34 | +2.3% | 638,400 |
2012/07/27 | 1,501 | 1,501 | 1,466 | 1,486 | -40 | -2.6% | 1,060,500 |
2012/07/26 | 1,548 | 1,548 | 1,506 | 1,526 | -17 | -1.1% | 815,500 |
2012/07/25 | 1,529 | 1,560 | 1,523 | 1,543 | +15 | +1% | 900,900 |
2012/07/24 | 1,528 | 1,538 | 1,523 | 1,528 | +1 | +0.1% | 627,000 |
2012/07/23 | 1,524 | 1,561 | 1,523 | 1,527 | -10 | -0.7% | 632,300 |
2012/07/20 | 1,543 | 1,569 | 1,537 | 1,537 | -29 | -1.9% | 981,200 |
2012/07/19 | 1,544 | 1,575 | 1,544 | 1,566 | +22 | +1.4% | 1,117,100 |
3101~
3150
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム